The U.S. approved a new COVID-19 vaccine made by Moderna late Friday but with limits on who can use it — not a replacement ...

The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna ...

The Food and Drug Administration has approved Moderna's new COVID-19 vaccine, days after the federal government tightened ...

Moderna's next COVID-19 vaccine has received Food and Drug Administration approval, albeit with restrictions not placed on ...

HHS has notified Moderna that it is canceling a nearly $600 million contract for vaccines for flu strains that could trigger ...

With the continued use of COVID-19 vaccines worldwide, there’s a massive amount of data that shows mRNA shots are safe.

A combination covid-19/flu vaccine could make it easier for people to get protection from both diseases. © Stockpot Videos via Shutterstock Moderna’s mRNA-based ...

Moderna researchers reported that the combo shot produced a stronger immune response against COVID-19 and most flu strains than the individual vaccines already on the market. The results were ...

Here’s why Researchers from vaccine-maker Moderna reported in a study published Wednesday that the new combo shot generated a stronger immune response against COVID-19 and most strains of flu ...

Moderna shared Phase 3 immunogenicity data for its flu/COVID combination vaccine (mRNA-1083) for adults aged 50 and older at its 2024 R&D Day event. The company submitted mRNA-1083 for ...

The Food and Drug Administration has asked Moderna for additional data before it will consider approving a combination shot the company developed for flu and COVID-19, the latest sign vaccines may ...